Segulah Venture AB säljer sina aktier i Spatial Transcriptomics AB10 december, 2018
Segulah Venture AB har ingått avtal om sälja sina aktier i Spatial Transcriptomics AB till amerikanska 10X Genomics.
“10x Genomics is on a quest to unlock a complete understanding of biology, and our recent growth and acquisition activities are accelerating our progress exponentially,” said Serge Saxonov, 10x Genomics’ CEO and co-founder. “We are thrilled to have the Spatial Transcriptomics team join forces with us. Now, researchers will not only be able to understand what is happening within a cell but also understand where cellular activities are happening in relation to one another. It’s another integral piece of the puzzle that gets us closer to seeing the whole picture of biology to drive new discoveries”
För ytterligare information, kontakta
Lars Axelson, VD Aktiebolaget Segulah, +46 70 511 51 30.